Compass Pathfinder Limited

Psychiatric Disorders

Compass Pathfinder Limited is focused on clinical research in treatment-resistant depression, with activity centered on adult patients whose depressive symptoms remain difficult to manage.

  • Depressive symptom improvement
  • Treatment-resistant depression
  • Adult mental health

The sponsor’s research interest is concentrated on depression within the broader field of psychiatry, reflecting a therapeutic focus on persistent mood disorders and unmet clinical need.

Psychological Support in Mental Health Care

Its clinical research includes the use of psychological support alongside treatment approaches for major depressive symptoms, highlighting the integration of mental health support within interventional care.

  • Psychological support
  • Adjunctive mental health care
  • Symptom-focused psychiatric treatment

This area places emphasis on the therapeutic management of mood disorders and the clinical role of supportive care in depression treatment.

Neuroscience and Brain Health

The sponsor’s research activity is also aligned with neuroscience, particularly conditions affecting emotional regulation, cognition, and overall brain health.

  • Neuropsychiatric conditions
  • Brain function
  • Emotional regulation

Its clinical interest lies in disorders where central nervous system pathways are implicated in persistent depressive illness.

Mental Health Therapeutics

Compass Pathfinder Limited is engaged in research related to mental health therapeutics, with particular attention to approaches intended to address ongoing depressive symptoms in adults.

  • Adult psychiatry
  • Depression therapeutics
  • Persistent mood symptoms

The sponsor’s clinical portfolio is concentrated on therapeutic innovation in psychiatry, especially for patients with limited response to existing depression treatments.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

    Not recruiting

    1 1 1
    Investigated drugs:
    Czechia Denmark France Germany Ireland The Netherlands +3